Joined Today: 1

SPPI Spectrum Pharmaceuticals, Stock Message Board

All Messages

SPPI Message Board Home | Join The SPPI Group |

#8: Pharmaceutical Stock : SPPI Stock News : New Data from Satraplatin Phase 3 Trial in Second-Line Castrate-Refractory Prostate Cancer Presented at 2009 ASCO Annual Meeting
TheMachine	June 11, 2009 12:56:52 AM
SPARC Trial Analyses Demonstrate Pain At Baseline, Pain Progression And Progression-Free Survival At Three Months Are Predictive Of Overall Survival In Metastatic... view message ignore post recommend post

#7: SPPI Stock News : ZEVALIN® Produced 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma Study
TheMachine	January 22, 2009 07:19:59 AM
Study Results Published in the January 15, 2009 Annals of Oncology Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI) announced today results of a study published by... view message ignore post recommend post

#6: Spectrum Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2008
TheMachine	September 20, 2008 01:21:46 AM
Recently Launched FDA Approved Drug – FUSILEV™ EOquin® In Phase 3 Registrational Trials in Non-Muscle Invasive Bladder Cancer ... view message ignore post recommend post

#5: FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
TheMachine	March 8, 2008 09:09:55 AM
Proprietary Drug Levoleucovorin For Injection (formerly known as ISO-Vorin™), A Novel Folate Analog, Is the First New Oncology Drug Approved By the FDA in 2008 ... view message ignore post recommend post

#4: Spectrum Pharmaceuticals Receives Approval from Canadian Authorities to Expand EOquin(R) Registrational, Phase 3 Clinical Trials into Canada
TheMachine	March 8, 2008 09:09:34 AM
Spectrum Pharmaceuticals, Inc., (Nasdaq:SPPI) today announced that the Therapeutic Product Directorate of Health Canada has approved the trials to be conducted in Canada... view message ignore post recommend post

#3: Spectrum Pharmaceuticals to Present at the Roth Capital Partners 20th Annual Orange County Growth Stock Conference
TheMachine	March 8, 2008 09:09:08 AM
Spectrum Pharmaceuticals, Inc., (Nasdaq:SPPI) announced today that Rajesh C. Shrotriya, M.D., President & Chief Executive Officer, will present an overview of the... view message ignore post recommend post

#2: Profile
FastFun	November 27, 2007 11:00:54 PM
Spectrum Pharmaceuticals, Inc. is engaged in the business of acquiring, developing and commercializing generic drug products that have a primary focus on the treatment of cancer and related... view message ignore post recommend post

#1: SPPI, Spectrum Pharmaceuticals to Present at the Friedman, Billings, Ramsey 11th Annual Growth Conference
Jason	June 3, 2007 09:18:04 PM
Spectrum Pharmaceuticals, Inc., (Nasdaq: SPPI StocksForum) announced today that Rajesh C. Shrotriya, M.D., Chairman, President and Chief Executive Officer of Spectrum Pharmaceuticals, will present... view message ignore post recommend post

Group Home | Login if you want to post a message